MUTAT RES-FUND MOL M 润色咨询

MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS

出版年份：1964 年文章数：23 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：3.9% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1095505, encodeId=eada1095505c8, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095506, encodeId=1364109550695, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577568, encodeId=23035e756838, content=这个杂志文章质量逐年下降，不知道今年换新主编是否能挽救一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Wed Oct 09 15:46:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540547, encodeId=5da854054e7c, content=可恨，去年我发表了一篇，还有2分多，今年就1分多了，明年难道还要降？谁愿意投它呢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13717005588, createdTime=Tue Jul 18 18:43:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540270, encodeId=e7365402e0f4, content=太狠了！跌了这么多，以后谁还敢投？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ding_ying, createdTime=Tue Jul 18 18:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=830419, encodeId=790f83041977, content=审稿速度:3.0<br>经验分享：投过3篇,其中录用2篇，被编辑拒稿1篇（原因是与前一篇有交叉内容）。感觉难度一般，但一定要有一个创新点和系统性。编辑耐心，但最近主编换人了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Tue Apr 28 18:53:22 CST 2015, time=2015-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506222, encodeId=574e506222e1, content=2014年2月28日投稿，很快进入审稿。但3位审稿专家物色及专家同意审稿则费了两个月才齐全，6月2日才得一审意见，大修，要求2月内修回。我们补做了一些实验，结果还有些新亮点。8月2日修回，9月5日二审意见为：Accept subjecy to minor revision。我们对几点意见作了修改或解释后于9月8日提交。8天后（9月16日）主编正式宣布接受。 <br> 感觉这个期刊比较严谨，为避免差错不惜多花时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=刘云岗, createdTime=Tue Sep 23 09:18:00 CST 2014, time=2014-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492488, encodeId=988e492488fa, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469698, encodeId=709346969874, content=杂志名称：Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis <br> 专业领域：毒理学 <br> 投稿日期：2009.6.2 <br> 投稿方式（投稿系统或者邮寄，如果有投稿系统请附上投稿链接：http://ees.elsevier.com/mut/ <br> 修回日期：2009.8.5拒稿 <br> 修改方式（大修，小修，拒稿）：拒稿 <br> 接受日期：否 <br> 是否收版面费：否 <br> 分享的经验或教训： <br> 1 Elsvier投稿系统，效率不敢恭维。投稿后一周编辑开始处理，两天后拒搞说是不符合杂志的scope。紧接着又发E-mail说取消拒稿，进入审稿状态。两月后编辑拒稿，还是说不符合杂志的投稿范畴，无任何审稿意见。 <br> 2 被拒原因：编辑认为是不符合杂志的投稿范畴。 <br> 3 个人觉得投这个杂志需慎重，原因：审稿慢，效率低，IF不稳定。 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=461, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=superlwb1982, createdTime=Tue Dec 15 13:04:00 CST 2009, time=2009-12-15, status=1, ipAttribution=)]
    2021-12-29 乌云背后的幸福线

    引言三段式指的是什么?

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1095505, encodeId=eada1095505c8, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095506, encodeId=1364109550695, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577568, encodeId=23035e756838, content=这个杂志文章质量逐年下降，不知道今年换新主编是否能挽救一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Wed Oct 09 15:46:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540547, encodeId=5da854054e7c, content=可恨，去年我发表了一篇，还有2分多，今年就1分多了，明年难道还要降？谁愿意投它呢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13717005588, createdTime=Tue Jul 18 18:43:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540270, encodeId=e7365402e0f4, content=太狠了！跌了这么多，以后谁还敢投？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ding_ying, createdTime=Tue Jul 18 18:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=830419, encodeId=790f83041977, content=审稿速度:3.0<br>经验分享：投过3篇,其中录用2篇，被编辑拒稿1篇（原因是与前一篇有交叉内容）。感觉难度一般，但一定要有一个创新点和系统性。编辑耐心，但最近主编换人了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Tue Apr 28 18:53:22 CST 2015, time=2015-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506222, encodeId=574e506222e1, content=2014年2月28日投稿，很快进入审稿。但3位审稿专家物色及专家同意审稿则费了两个月才齐全，6月2日才得一审意见，大修，要求2月内修回。我们补做了一些实验，结果还有些新亮点。8月2日修回，9月5日二审意见为：Accept subjecy to minor revision。我们对几点意见作了修改或解释后于9月8日提交。8天后（9月16日）主编正式宣布接受。 <br> 感觉这个期刊比较严谨，为避免差错不惜多花时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=刘云岗, createdTime=Tue Sep 23 09:18:00 CST 2014, time=2014-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492488, encodeId=988e492488fa, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469698, encodeId=709346969874, content=杂志名称：Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis <br> 专业领域：毒理学 <br> 投稿日期：2009.6.2 <br> 投稿方式（投稿系统或者邮寄，如果有投稿系统请附上投稿链接：http://ees.elsevier.com/mut/ <br> 修回日期：2009.8.5拒稿 <br> 修改方式（大修，小修，拒稿）：拒稿 <br> 接受日期：否 <br> 是否收版面费：否 <br> 分享的经验或教训： <br> 1 Elsvier投稿系统，效率不敢恭维。投稿后一周编辑开始处理，两天后拒搞说是不符合杂志的scope。紧接着又发E-mail说取消拒稿，进入审稿状态。两月后编辑拒稿，还是说不符合杂志的投稿范畴，无任何审稿意见。 <br> 2 被拒原因：编辑认为是不符合杂志的投稿范畴。 <br> 3 个人觉得投这个杂志需慎重，原因：审稿慢，效率低，IF不稳定。 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=461, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=superlwb1982, createdTime=Tue Dec 15 13:04:00 CST 2009, time=2009-12-15, status=1, ipAttribution=)]
    2021-12-29 小动量

    结果中的重要文献是在结果体现，还是在引言中描述？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1095505, encodeId=eada1095505c8, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095506, encodeId=1364109550695, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577568, encodeId=23035e756838, content=这个杂志文章质量逐年下降，不知道今年换新主编是否能挽救一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Wed Oct 09 15:46:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540547, encodeId=5da854054e7c, content=可恨，去年我发表了一篇，还有2分多，今年就1分多了，明年难道还要降？谁愿意投它呢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13717005588, createdTime=Tue Jul 18 18:43:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540270, encodeId=e7365402e0f4, content=太狠了！跌了这么多，以后谁还敢投？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ding_ying, createdTime=Tue Jul 18 18:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=830419, encodeId=790f83041977, content=审稿速度:3.0<br>经验分享：投过3篇,其中录用2篇，被编辑拒稿1篇（原因是与前一篇有交叉内容）。感觉难度一般，但一定要有一个创新点和系统性。编辑耐心，但最近主编换人了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Tue Apr 28 18:53:22 CST 2015, time=2015-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506222, encodeId=574e506222e1, content=2014年2月28日投稿，很快进入审稿。但3位审稿专家物色及专家同意审稿则费了两个月才齐全，6月2日才得一审意见，大修，要求2月内修回。我们补做了一些实验，结果还有些新亮点。8月2日修回，9月5日二审意见为：Accept subjecy to minor revision。我们对几点意见作了修改或解释后于9月8日提交。8天后（9月16日）主编正式宣布接受。 <br> 感觉这个期刊比较严谨，为避免差错不惜多花时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=刘云岗, createdTime=Tue Sep 23 09:18:00 CST 2014, time=2014-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492488, encodeId=988e492488fa, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469698, encodeId=709346969874, content=杂志名称：Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis <br> 专业领域：毒理学 <br> 投稿日期：2009.6.2 <br> 投稿方式（投稿系统或者邮寄，如果有投稿系统请附上投稿链接：http://ees.elsevier.com/mut/ <br> 修回日期：2009.8.5拒稿 <br> 修改方式（大修，小修，拒稿）：拒稿 <br> 接受日期：否 <br> 是否收版面费：否 <br> 分享的经验或教训： <br> 1 Elsvier投稿系统，效率不敢恭维。投稿后一周编辑开始处理，两天后拒搞说是不符合杂志的scope。紧接着又发E-mail说取消拒稿，进入审稿状态。两月后编辑拒稿，还是说不符合杂志的投稿范畴，无任何审稿意见。 <br> 2 被拒原因：编辑认为是不符合杂志的投稿范畴。 <br> 3 个人觉得投这个杂志需慎重，原因：审稿慢，效率低，IF不稳定。 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=461, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=superlwb1982, createdTime=Tue Dec 15 13:04:00 CST 2009, time=2009-12-15, status=1, ipAttribution=)]
    2019-10-09 da-xiang

    这个杂志文章质量逐年下降，不知道今年换新主编是否能挽救一下

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1095505, encodeId=eada1095505c8, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095506, encodeId=1364109550695, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577568, encodeId=23035e756838, content=这个杂志文章质量逐年下降，不知道今年换新主编是否能挽救一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Wed Oct 09 15:46:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540547, encodeId=5da854054e7c, content=可恨，去年我发表了一篇，还有2分多，今年就1分多了，明年难道还要降？谁愿意投它呢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13717005588, createdTime=Tue Jul 18 18:43:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540270, encodeId=e7365402e0f4, content=太狠了！跌了这么多，以后谁还敢投？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ding_ying, createdTime=Tue Jul 18 18:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=830419, encodeId=790f83041977, content=审稿速度:3.0<br>经验分享：投过3篇,其中录用2篇，被编辑拒稿1篇（原因是与前一篇有交叉内容）。感觉难度一般，但一定要有一个创新点和系统性。编辑耐心，但最近主编换人了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Tue Apr 28 18:53:22 CST 2015, time=2015-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506222, encodeId=574e506222e1, content=2014年2月28日投稿，很快进入审稿。但3位审稿专家物色及专家同意审稿则费了两个月才齐全，6月2日才得一审意见，大修，要求2月内修回。我们补做了一些实验，结果还有些新亮点。8月2日修回，9月5日二审意见为：Accept subjecy to minor revision。我们对几点意见作了修改或解释后于9月8日提交。8天后（9月16日）主编正式宣布接受。 <br> 感觉这个期刊比较严谨，为避免差错不惜多花时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=刘云岗, createdTime=Tue Sep 23 09:18:00 CST 2014, time=2014-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492488, encodeId=988e492488fa, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469698, encodeId=709346969874, content=杂志名称：Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis <br> 专业领域：毒理学 <br> 投稿日期：2009.6.2 <br> 投稿方式（投稿系统或者邮寄，如果有投稿系统请附上投稿链接：http://ees.elsevier.com/mut/ <br> 修回日期：2009.8.5拒稿 <br> 修改方式（大修，小修，拒稿）：拒稿 <br> 接受日期：否 <br> 是否收版面费：否 <br> 分享的经验或教训： <br> 1 Elsvier投稿系统，效率不敢恭维。投稿后一周编辑开始处理，两天后拒搞说是不符合杂志的scope。紧接着又发E-mail说取消拒稿，进入审稿状态。两月后编辑拒稿，还是说不符合杂志的投稿范畴，无任何审稿意见。 <br> 2 被拒原因：编辑认为是不符合杂志的投稿范畴。 <br> 3 个人觉得投这个杂志需慎重，原因：审稿慢，效率低，IF不稳定。 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=461, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=superlwb1982, createdTime=Tue Dec 15 13:04:00 CST 2009, time=2009-12-15, status=1, ipAttribution=)]
    2017-07-18 13717005588

    可恨，去年我发表了一篇，还有2分多，今年就1分多了，明年难道还要降？谁愿意投它呢！

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1095505, encodeId=eada1095505c8, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095506, encodeId=1364109550695, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577568, encodeId=23035e756838, content=这个杂志文章质量逐年下降，不知道今年换新主编是否能挽救一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Wed Oct 09 15:46:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540547, encodeId=5da854054e7c, content=可恨，去年我发表了一篇，还有2分多，今年就1分多了，明年难道还要降？谁愿意投它呢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13717005588, createdTime=Tue Jul 18 18:43:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540270, encodeId=e7365402e0f4, content=太狠了！跌了这么多，以后谁还敢投？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ding_ying, createdTime=Tue Jul 18 18:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=830419, encodeId=790f83041977, content=审稿速度:3.0<br>经验分享：投过3篇,其中录用2篇，被编辑拒稿1篇（原因是与前一篇有交叉内容）。感觉难度一般，但一定要有一个创新点和系统性。编辑耐心，但最近主编换人了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Tue Apr 28 18:53:22 CST 2015, time=2015-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506222, encodeId=574e506222e1, content=2014年2月28日投稿，很快进入审稿。但3位审稿专家物色及专家同意审稿则费了两个月才齐全，6月2日才得一审意见，大修，要求2月内修回。我们补做了一些实验，结果还有些新亮点。8月2日修回，9月5日二审意见为：Accept subjecy to minor revision。我们对几点意见作了修改或解释后于9月8日提交。8天后（9月16日）主编正式宣布接受。 <br> 感觉这个期刊比较严谨，为避免差错不惜多花时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=刘云岗, createdTime=Tue Sep 23 09:18:00 CST 2014, time=2014-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492488, encodeId=988e492488fa, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469698, encodeId=709346969874, content=杂志名称：Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis <br> 专业领域：毒理学 <br> 投稿日期：2009.6.2 <br> 投稿方式（投稿系统或者邮寄，如果有投稿系统请附上投稿链接：http://ees.elsevier.com/mut/ <br> 修回日期：2009.8.5拒稿 <br> 修改方式（大修，小修，拒稿）：拒稿 <br> 接受日期：否 <br> 是否收版面费：否 <br> 分享的经验或教训： <br> 1 Elsvier投稿系统，效率不敢恭维。投稿后一周编辑开始处理，两天后拒搞说是不符合杂志的scope。紧接着又发E-mail说取消拒稿，进入审稿状态。两月后编辑拒稿，还是说不符合杂志的投稿范畴，无任何审稿意见。 <br> 2 被拒原因：编辑认为是不符合杂志的投稿范畴。 <br> 3 个人觉得投这个杂志需慎重，原因：审稿慢，效率低，IF不稳定。 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=461, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=superlwb1982, createdTime=Tue Dec 15 13:04:00 CST 2009, time=2009-12-15, status=1, ipAttribution=)]
    2017-07-18 ding_ying

    太狠了！跌了这么多，以后谁还敢投？？

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1095505, encodeId=eada1095505c8, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095506, encodeId=1364109550695, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577568, encodeId=23035e756838, content=这个杂志文章质量逐年下降，不知道今年换新主编是否能挽救一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Wed Oct 09 15:46:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540547, encodeId=5da854054e7c, content=可恨，去年我发表了一篇，还有2分多，今年就1分多了，明年难道还要降？谁愿意投它呢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13717005588, createdTime=Tue Jul 18 18:43:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540270, encodeId=e7365402e0f4, content=太狠了！跌了这么多，以后谁还敢投？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ding_ying, createdTime=Tue Jul 18 18:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=830419, encodeId=790f83041977, content=审稿速度:3.0<br>经验分享：投过3篇,其中录用2篇，被编辑拒稿1篇（原因是与前一篇有交叉内容）。感觉难度一般，但一定要有一个创新点和系统性。编辑耐心，但最近主编换人了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Tue Apr 28 18:53:22 CST 2015, time=2015-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506222, encodeId=574e506222e1, content=2014年2月28日投稿，很快进入审稿。但3位审稿专家物色及专家同意审稿则费了两个月才齐全，6月2日才得一审意见，大修，要求2月内修回。我们补做了一些实验，结果还有些新亮点。8月2日修回，9月5日二审意见为：Accept subjecy to minor revision。我们对几点意见作了修改或解释后于9月8日提交。8天后（9月16日）主编正式宣布接受。 <br> 感觉这个期刊比较严谨，为避免差错不惜多花时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=刘云岗, createdTime=Tue Sep 23 09:18:00 CST 2014, time=2014-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492488, encodeId=988e492488fa, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469698, encodeId=709346969874, content=杂志名称：Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis <br> 专业领域：毒理学 <br> 投稿日期：2009.6.2 <br> 投稿方式（投稿系统或者邮寄，如果有投稿系统请附上投稿链接：http://ees.elsevier.com/mut/ <br> 修回日期：2009.8.5拒稿 <br> 修改方式（大修，小修，拒稿）：拒稿 <br> 接受日期：否 <br> 是否收版面费：否 <br> 分享的经验或教训： <br> 1 Elsvier投稿系统，效率不敢恭维。投稿后一周编辑开始处理，两天后拒搞说是不符合杂志的scope。紧接着又发E-mail说取消拒稿，进入审稿状态。两月后编辑拒稿，还是说不符合杂志的投稿范畴，无任何审稿意见。 <br> 2 被拒原因：编辑认为是不符合杂志的投稿范畴。 <br> 3 个人觉得投这个杂志需慎重，原因：审稿慢，效率低，IF不稳定。 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=461, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=superlwb1982, createdTime=Tue Dec 15 13:04:00 CST 2009, time=2009-12-15, status=1, ipAttribution=)]
    2015-04-28 ms3214948925389860

    审稿速度:3.0
    经验分享：投过3篇,其中录用2篇，被编辑拒稿1篇（原因是与前一篇有交叉内容）。感觉难度一般，但一定要有一个创新点和系统性。编辑耐心，但最近主编换人了。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1095505, encodeId=eada1095505c8, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095506, encodeId=1364109550695, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577568, encodeId=23035e756838, content=这个杂志文章质量逐年下降，不知道今年换新主编是否能挽救一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Wed Oct 09 15:46:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540547, encodeId=5da854054e7c, content=可恨，去年我发表了一篇，还有2分多，今年就1分多了，明年难道还要降？谁愿意投它呢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13717005588, createdTime=Tue Jul 18 18:43:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540270, encodeId=e7365402e0f4, content=太狠了！跌了这么多，以后谁还敢投？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ding_ying, createdTime=Tue Jul 18 18:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=830419, encodeId=790f83041977, content=审稿速度:3.0<br>经验分享：投过3篇,其中录用2篇，被编辑拒稿1篇（原因是与前一篇有交叉内容）。感觉难度一般，但一定要有一个创新点和系统性。编辑耐心，但最近主编换人了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Tue Apr 28 18:53:22 CST 2015, time=2015-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506222, encodeId=574e506222e1, content=2014年2月28日投稿，很快进入审稿。但3位审稿专家物色及专家同意审稿则费了两个月才齐全，6月2日才得一审意见，大修，要求2月内修回。我们补做了一些实验，结果还有些新亮点。8月2日修回，9月5日二审意见为：Accept subjecy to minor revision。我们对几点意见作了修改或解释后于9月8日提交。8天后（9月16日）主编正式宣布接受。 <br> 感觉这个期刊比较严谨，为避免差错不惜多花时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=刘云岗, createdTime=Tue Sep 23 09:18:00 CST 2014, time=2014-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492488, encodeId=988e492488fa, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469698, encodeId=709346969874, content=杂志名称：Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis <br> 专业领域：毒理学 <br> 投稿日期：2009.6.2 <br> 投稿方式（投稿系统或者邮寄，如果有投稿系统请附上投稿链接：http://ees.elsevier.com/mut/ <br> 修回日期：2009.8.5拒稿 <br> 修改方式（大修，小修，拒稿）：拒稿 <br> 接受日期：否 <br> 是否收版面费：否 <br> 分享的经验或教训： <br> 1 Elsvier投稿系统，效率不敢恭维。投稿后一周编辑开始处理，两天后拒搞说是不符合杂志的scope。紧接着又发E-mail说取消拒稿，进入审稿状态。两月后编辑拒稿，还是说不符合杂志的投稿范畴，无任何审稿意见。 <br> 2 被拒原因：编辑认为是不符合杂志的投稿范畴。 <br> 3 个人觉得投这个杂志需慎重，原因：审稿慢，效率低，IF不稳定。 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=461, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=superlwb1982, createdTime=Tue Dec 15 13:04:00 CST 2009, time=2009-12-15, status=1, ipAttribution=)]
    2014-09-23 刘云岗

    2014年2月28日投稿，很快进入审稿。但3位审稿专家物色及专家同意审稿则费了两个月才齐全，6月2日才得一审意见，大修，要求2月内修回。我们补做了一些实验，结果还有些新亮点。8月2日修回，9月5日二审意见为：Accept subjecy to minor revision。我们对几点意见作了修改或解释后于9月8日提交。8天后（9月16日）主编正式宣布接受。
    感觉这个期刊比较严谨，为避免差错不惜多花时间。

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1095505, encodeId=eada1095505c8, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095506, encodeId=1364109550695, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577568, encodeId=23035e756838, content=这个杂志文章质量逐年下降，不知道今年换新主编是否能挽救一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Wed Oct 09 15:46:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540547, encodeId=5da854054e7c, content=可恨，去年我发表了一篇，还有2分多，今年就1分多了，明年难道还要降？谁愿意投它呢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13717005588, createdTime=Tue Jul 18 18:43:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540270, encodeId=e7365402e0f4, content=太狠了！跌了这么多，以后谁还敢投？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ding_ying, createdTime=Tue Jul 18 18:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=830419, encodeId=790f83041977, content=审稿速度:3.0<br>经验分享：投过3篇,其中录用2篇，被编辑拒稿1篇（原因是与前一篇有交叉内容）。感觉难度一般，但一定要有一个创新点和系统性。编辑耐心，但最近主编换人了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Tue Apr 28 18:53:22 CST 2015, time=2015-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506222, encodeId=574e506222e1, content=2014年2月28日投稿，很快进入审稿。但3位审稿专家物色及专家同意审稿则费了两个月才齐全，6月2日才得一审意见，大修，要求2月内修回。我们补做了一些实验，结果还有些新亮点。8月2日修回，9月5日二审意见为：Accept subjecy to minor revision。我们对几点意见作了修改或解释后于9月8日提交。8天后（9月16日）主编正式宣布接受。 <br> 感觉这个期刊比较严谨，为避免差错不惜多花时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=刘云岗, createdTime=Tue Sep 23 09:18:00 CST 2014, time=2014-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492488, encodeId=988e492488fa, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469698, encodeId=709346969874, content=杂志名称：Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis <br> 专业领域：毒理学 <br> 投稿日期：2009.6.2 <br> 投稿方式（投稿系统或者邮寄，如果有投稿系统请附上投稿链接：http://ees.elsevier.com/mut/ <br> 修回日期：2009.8.5拒稿 <br> 修改方式（大修，小修，拒稿）：拒稿 <br> 接受日期：否 <br> 是否收版面费：否 <br> 分享的经验或教训： <br> 1 Elsvier投稿系统，效率不敢恭维。投稿后一周编辑开始处理，两天后拒搞说是不符合杂志的scope。紧接着又发E-mail说取消拒稿，进入审稿状态。两月后编辑拒稿，还是说不符合杂志的投稿范畴，无任何审稿意见。 <br> 2 被拒原因：编辑认为是不符合杂志的投稿范畴。 <br> 3 个人觉得投这个杂志需慎重，原因：审稿慢，效率低，IF不稳定。 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=461, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=superlwb1982, createdTime=Tue Dec 15 13:04:00 CST 2009, time=2009-12-15, status=1, ipAttribution=)]
    2012-11-28 qupeter

    明年能不能冲到3分？大家谈谈

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1095505, encodeId=eada1095505c8, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095506, encodeId=1364109550695, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577568, encodeId=23035e756838, content=这个杂志文章质量逐年下降，不知道今年换新主编是否能挽救一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Wed Oct 09 15:46:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540547, encodeId=5da854054e7c, content=可恨，去年我发表了一篇，还有2分多，今年就1分多了，明年难道还要降？谁愿意投它呢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13717005588, createdTime=Tue Jul 18 18:43:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540270, encodeId=e7365402e0f4, content=太狠了！跌了这么多，以后谁还敢投？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ding_ying, createdTime=Tue Jul 18 18:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=830419, encodeId=790f83041977, content=审稿速度:3.0<br>经验分享：投过3篇,其中录用2篇，被编辑拒稿1篇（原因是与前一篇有交叉内容）。感觉难度一般，但一定要有一个创新点和系统性。编辑耐心，但最近主编换人了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Tue Apr 28 18:53:22 CST 2015, time=2015-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506222, encodeId=574e506222e1, content=2014年2月28日投稿，很快进入审稿。但3位审稿专家物色及专家同意审稿则费了两个月才齐全，6月2日才得一审意见，大修，要求2月内修回。我们补做了一些实验，结果还有些新亮点。8月2日修回，9月5日二审意见为：Accept subjecy to minor revision。我们对几点意见作了修改或解释后于9月8日提交。8天后（9月16日）主编正式宣布接受。 <br> 感觉这个期刊比较严谨，为避免差错不惜多花时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=刘云岗, createdTime=Tue Sep 23 09:18:00 CST 2014, time=2014-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492488, encodeId=988e492488fa, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469698, encodeId=709346969874, content=杂志名称：Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis <br> 专业领域：毒理学 <br> 投稿日期：2009.6.2 <br> 投稿方式（投稿系统或者邮寄，如果有投稿系统请附上投稿链接：http://ees.elsevier.com/mut/ <br> 修回日期：2009.8.5拒稿 <br> 修改方式（大修，小修，拒稿）：拒稿 <br> 接受日期：否 <br> 是否收版面费：否 <br> 分享的经验或教训： <br> 1 Elsvier投稿系统，效率不敢恭维。投稿后一周编辑开始处理，两天后拒搞说是不符合杂志的scope。紧接着又发E-mail说取消拒稿，进入审稿状态。两月后编辑拒稿，还是说不符合杂志的投稿范畴，无任何审稿意见。 <br> 2 被拒原因：编辑认为是不符合杂志的投稿范畴。 <br> 3 个人觉得投这个杂志需慎重，原因：审稿慢，效率低，IF不稳定。 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=461, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=superlwb1982, createdTime=Tue Dec 15 13:04:00 CST 2009, time=2009-12-15, status=1, ipAttribution=)]
    2009-12-15 superlwb1982

    杂志名称：Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
    专业领域：毒理学
    投稿日期：2009.6.2
    投稿方式（投稿系统或者邮寄，如果有投稿系统请附上投稿链接：http://ees.elsevier.com/mut/
    修回日期：2009.8.5拒稿
    修改方式（大修，小修，拒稿）：拒稿
    接受日期：否
    是否收版面费：否
    分享的经验或教训：
    1 Elsvier投稿系统，效率不敢恭维。投稿后一周编辑开始处理，两天后拒搞说是不符合杂志的scope。紧接着又发E-mail说取消拒稿，进入审稿状态。两月后编辑拒稿，还是说不符合杂志的投稿范畴，无任何审稿意见。
    2 被拒原因：编辑认为是不符合杂志的投稿范畴。
    3 个人觉得投这个杂志需慎重，原因：审稿慢，效率低，IF不稳定。

    0

共11条页码: 1/2页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分